# Study in Pediatric Subjects Evaluating Pharmacokinetics and Safety of EXPAREL

> **NCT03485014** · PHASE1 · COMPLETED · sponsor: **Pacira Pharmaceuticals, Inc** · enrollment: 15 (actual)

## Conditions studied

- Postoperative Pain Management

## Interventions

- **DRUG:** Exparel

## Key facts

- **NCT ID:** NCT03485014
- **Lead sponsor:** Pacira Pharmaceuticals, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-10
- **Primary completion:** 2019-02-12
- **Final completion:** 2019-02-12
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2023-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03485014

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03485014, "Study in Pediatric Subjects Evaluating Pharmacokinetics and Safety of EXPAREL". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03485014. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*